Skip to main content Skip to main navigation menu Skip to site footer

Penanganan kandidiasis orofaring pada pasien Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome (HIV/AIDS) dengan nilai CD4 dibawah 10 sel/µL: laporan kasus

  • Winda Dwi Malinda Masuku ,
  • Dian Angriany ,
  • Saka Winias ,
  • Adiastuti Endah Parmadiati ,


Abstract

Background: The oral manifestation of Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome (HIV/AIDS) is an important indicator because it is a disorder that usually appears first when the immune system is suppressed. Oropharyngeal candidiasis is an opportunistic infection that most often occurs in people suffering from HIV infection or AIDS. It is also an important marker in immunosuppressed states with CD4 values below 200 cells/mm3. This case study aims to evaluate the treatment of oropharyngeal candidiasis in patients with HIV/AIDS with CD4 values below 10 cells/µL

Case Presentation: A 30-year-old man complained of a thick and uncomfortable feeling in the entire oral cavity felt since 4 months ago. Clinical examination revealed multiple pseudomembranous, which were removed and left a reddish area at the base of most of the oral cavity to the pharynx. The results of the fungal examination showed that the hyphae were not insulated with the results of candida albicans culture, and the absolute CD4 value was 9 cells/µl. On the second visit, the patient admitted that he was HIV positive by bringing a reactive result on the 3-method anti-HIV examination conducted 3 months earlier. This case was handled by administering an antiseptic mouthwash, topical and systemic antifungal, and referred to the IHAN RSUA polyclinic for ARV therapy.

Conclusion: The successful treatment of oropharyngeal candidiasis, in this case, depends on integrated therapy between dentists and internists as well as patient compliance in following doctor's instructions.

 

Latar Belakang: Manifestasi oral Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome (HIV/AIDS) menjadi indikator penting karena merupakan kelainan yang biasanya muncul pertama kali saat kondisi imun tersupresi. Kandidiasis orofaring merupakan suatu infeksi oportunistik yang paling sering terjadi pada orang yang menderita infeksi HIV atau AIDS. Hal ini juga disadari sebagai suatu pertanda penting pada keadaan imunosupresi dengan nilai CD4 dibawah 200 sel/mm3. Laporan kasus ini bertujuan untuk mengevaluasi penanganan kandidiasis orofaring pada pasien (HIV/AIDS) dengan nilai CD4 dibawah 10 sel/µL

Presentasi Kasus: Seorang laki-laki berusia 30 tahun mengeluhkan rasa tebal dan tidak nyaman pada seluruh rongga mulut yang dirasakan sejak 4 bulan yang lalu. Pemeriksaan klinis ditemukan pseudomembran multipel yang dapat dihapus dan meninggalkan area kemerahan di dasarnya pada hampir seluruh rongga mulut hingga ke faring. Hasil pemeriksaan jamur menunjukkan hyphae tidak bersekat dengan hasil biakan candida albicans, dan nilai CD4 absolut 9 cell/µl. Kunjungan kedua Pasien mengakui sebagai pengidap HIV dengan membawa hasil reaktif pada pemeriksaan anti-HIV 3 metode yang telah dilakukan 3 bulan sebelumnya. Penanganan kasus ini dengan pemberian antiseptik kumur, anti jamur topikal dan sistemik serta dirujuk ke poli IHAN RSUA untuk melakukan terapi ARV.

Kesimpulan: Keberhasilan penanganan kandidiasis orofaringeal pada kasus ini bergantung pada terapi yang terintegrasi antara dokter gigi dan dokter penyakit dalam serta kepatuhan pasien dalam mengikuti instruksi dokter. 

Keywords: Kandidiasis Orofaring Candida albicans Kandidiasis Pseudomembran HIV AIDS CD4

References

  1. Majid ZSA, Taher EM. A Case Report of Pseudomembranous Candidiasis Induced by Long Term Systemic Corticosteroid Therapy. Int J Dent Health Sci 2015;2(2):454-458.
  2. Mukherjee M, Basak S, Guha SK, Dutta D, Chakraborty A. Oropharyngeal Candidiasis in HIV/AIDS : A Hospital Based Co-Relation Study. International Journal of Research In Medical and Health Sciences. 2014;4(4):19-23.
  3. Patil S, Majumdar B, Sarode SC, Sarode GS, Awan KH. Oropharyngeal Candidosis in HIV-Infected Patients-An Update. Front Microbiol. 2018;9:980.
  4. Nelwan EJ. HIV Infection in Indonesia. Acta Medica Indonesiana. 2017;49(3):193-194.
  5. Murtiastutik D, Prakoeswa CRS, Tantular IS. Fluconazole Resistant Oral Candidiasis on HIV Patient-What Other Drug can We Choose? A Case Report. J Pure Appl Microbiol. 2020;14(1):31-36.
  6. Aškinyt? D, Matulionyt? R, Rimkevi?ius A. Oral manifestations of HIV disease: A review. Stomatologija. 2015;17(1):21-28.
  7. Vargas KG, Joly S. Carriage frequency, intensity of carriage, and strains of oral yeast species vary in the progression to oral candidiasis in human immunodeficiency virus-positive individuals. J Clin Microbiol. 2002;40(2):341-350.
  8. Bodhade AS, Ganvir SM, Hazarey VK. Oral manifestations of HIV infection and their correlation with CD4 count. J Oral Sci. 2011;53(2):203-211.
  9. Rodrigues CF, Rodrigues ME, Henriques M. Candida sp. Infections in Patients with Diabetes Mellitus. J Clin Med. 2019;8(1):76.
  10. Katoh T. Guidelines for diagnosis and treatment of mucocutaneous candidiasis. 2009;50(4):207-212.
  11. Rathod T, Padalia H, Chanda S. Anticandidal and synergistic anticandidal activity and chemical composition of citrus reticulate and Azadirachta indica essential oil. Journal of Pharmacy. 2017;7(9):52-71.
  12. Van Wyk C, Steenkamp V. Host factors affecting oral candidiasis. South Afr J Epidemiol Infect. 2011;26(1):18-21.
  13. Chu X. Oral Candidiasis: relation to systemic diseases and medications. Dentistry 3000. 2017;5(1):1-9.
  14. Rathod P, Punga R, Dalal V, Rathod D. Oral Candidiasis-Widely Prevalent, Frequently Missed. International Journal of Scientific Study. 2015;3(6):193-194.
  15. Williams D, Lewis M. Pathogenesis and treatment of oral candidosis. J Oral Microbiol. 2011;3:10.3402/jom.v3i0.5771.
  16. Patil S, Rao RS, Majumdar B, Anil S. Clinical Appearance of Oral Candida Infection and Therapeutic Strategies. Front Microbiol. 2015;6:1391.
  17. Ranganathan K, Reddy BV, Kumarasamy N, Solomon S, Viswanathan R, Johnson NW. Oral lesions and conditions associated with human immunodeficiency virus infection in 300 south Indian patients. Oral Dis. 2000;6(3):152-157.
  18. Frimpong P, Amponsah EK, Abebrese J, Kim SM. Oral manifestations and their correlation to baseline CD4 count of HIV/AIDS patients in Ghana. J Korean Assoc Oral Maxillofac Surg. 2017;43(1):29-36.
  19. Shetti A, Gupta I, Charantimath SM. Oral Candidiasis: Aiding in the Diagnosis of HIV-A Case Report. Case Rep Dent. 2011;2011:929616.
  20. Wande IN, Fuadi MR, Hadi S. The Correlation between total lymphocyte count, hemoglobin levels, lymphocyte/leukocyte ratio (LLR), and lymphocyte/neutrophil ratio (LNR) to CD4 levels in patients with Human Immunodeficiency Virus infection at Sanglah Hospital. Bali Medical Journal. 2019;8(2):337-341.
  21. Afiah A, Arif M, Hardjoeno. Profil tes darah rutin dan jumlah limfosit total pada penderita HIV/AIDS. Indonesian Journal of Clinical Pathology and Medical Laboratory. 2007;13(2):56-59.
  22. Lau B, Gange SJ, Phair JP, Riddler SA, Detels R, Margolick JB. Use of total lymphocyte count and hemoglobin concentration for monitoring progression of HIV infection. J Acquir Immune Defic Syndr. 2005;39(5):620-625.
  23. Rampa E, Prastyawati R, Sinaga H. Pemeriksaan Kadar Ureum dan Kreatinin Pasien HIV yang Mendapatkan Terapi ARV di Puskesmas Harapan Sentani Kabupaten Jayapura Papua. Jurnal Penelitian Kesehatan Suara Forikes. 2019;10(3):223-226.
  24. Teck R, Ascurra O, Gomani P, Manzi M, Pasulani O, Kusamale J, et al. WHO clinical staging of HIV infection and disease, tuberculosis and eligibility for antiretroviral treatment: relationship to CD4 lymphocyte counts. Int J Tuberc Lung Dis. 2005;9(3):258-62.
  25. van de Veerdonk FL, Netea MG, Joosten LA, van der Meer JW, Kullberg BJ. Novel strategies for the prevention and treatment of Candida infections: the potential of immunotherapy. FEMS Microbiol Rev. 2010;34(6):1063-1075.
  26. Rahayu RP, Prasetyo RA, Purwanto DA, Kresnoadi U, Iskandar RPD, Rubianto M. The immunomodulatory effect of green tea (Camellia sinensis) leaves extract on immunocompromised Wistar rats infected by Candida albicans. Vet World. 2018;11(6):765-770.
  27. Jiang S. Immunity against Fungal Infections. Immunology and Immunogenetics Insights. 2016:8:3–6.
  28. Kwara A, Flanigan TP, Carter EJ. Highly active antiretroviral therapy (HAART) in adults with tuberculosis: current status. Int J Tuberc Lung Dis. 2005;9(3):248-257.
  29. Heath KV, Singer J, O'Shaughnessy MV, Montaner JS, Hogg RS. Intentional nonadherence due to adverse symptoms associated with antiretroviral therapy. J Acquir Immune Defic Syndr. 2002;31(2):211-217.

How to Cite

Masuku, W. D. M., Angriany, D., Winias, S., & Parmadiati, A. E. (2021). Penanganan kandidiasis orofaring pada pasien Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome (HIV/AIDS) dengan nilai CD4 dibawah 10 sel/µL: laporan kasus. Intisari Sains Medis, 12(2), 627–634. https://doi.org/10.15562/ism.v12i2.1077
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver
Download Citation
Endnote/Zotero/Mendeley (RIS) BibTeX

HTML
379

Total
1784

Share

Search Panel

Winda Dwi Malinda Masuku
Google Scholar
Pubmed
ISM Journal

Dian Angriany
Google Scholar
Pubmed
ISM Journal

Saka Winias
Google Scholar
Pubmed
ISM Journal

Adiastuti Endah Parmadiati
Google Scholar
Pubmed
ISM Journal